JOSE ANGEL
BEREZO GARCIA
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Pío del Río Hortega (19)
2023
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
-
Programa de optimización del uso de antimicrobianos en un Servicio de Medicina Intensiva: análisis retrospectivo observacional de los resultados 15 meses después de su implementación
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 477-485
2022
-
Determinants of mortality in cancer patients with unscheduled admission to the Intensive Care Unit: A prospective multicenter study
Medicina Intensiva, Vol. 46, Núm. 12, pp. 669-679
-
Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients
Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2020
-
Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events
Internal and Emergency Medicine, Vol. 15, Núm. 8, pp. 1533-1544
-
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
Critical Care, Vol. 24, Núm. 1
2018
-
Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study
Critical Care, Vol. 22, Núm. 1
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2014
-
Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma
Journal of Pain and Symptom Management
-
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Journal of Clinical Virology
2013
-
IgM levels in plasma predict outcome in severe pandemic influenza
Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567
2012
-
Antibiotic prescription patterns in the empiric therapy of severe sepsis: Combination of antimicrobials with different mechanisms of action reduces mortality
Critical Care, Vol. 16, Núm. 6
-
Viral infection is associated with an increased proinflammatory response in chronic obstructive pulmonary disease
Viral Immunology, Vol. 25, Núm. 4, pp. 249-253
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85